Диссертация (1140680), страница 25
Текст из файла (страница 25)
5. – P. 95-97.156. Nordling, J. Global Concepts of Bladder Pain Syndrome (InterstitialCystitis) / J. Nordling, M. Fall, P. M. Hanno // World Journal of Urology. – 2012.– Vol. 30, № 4. – P. 457-464.157. Nordling, J. Intravesical glycosaminoglycan replenishment with chondroitinsulphate in chronic forms of cystitis. A multinational, multi-centre, prospectiveobservational clinical trial / Nordling J., van Ophoven A.
// Arzneimittelforschung.– 2008. – P. 328.158. Parsons, C.L. The role of the urinary epithelium in the pathogenesis ofinterstitial cystitis/prostatitis/urethritis / C.L. Parsons // Urology. – 2007. – № 69. –P. 9–16.159. Parsons, J.K. Benign Prostatic Hyperplasia and Male Lower Urinary TractSymptoms: Epidemiology and Risk Factors. / J.K.
Parsons // Current BladderDysfunction Reports. – 2010. – Vol. 5, № 4. – P. 212-218.160. Patel, A.Transurethral electrovaporization and Vapour-resection of theprostate / A. Patel, G. Fuchs // British Journal of Urology. – 2000. – Vol. 85. – P.202-210.161. Pentosan polysulfate sodium for treatment of interstitial cystitis/bladder pain159syndrome: Insights from a randomized, double-blind, placebo controlled study /J.C. Nickel [et al.]. // J Urol.
– 2015. – № 193. – P. 857-862.162. Practice patterns in benign prostatic hyperplasia surgical therapy: thedramatic increase in minimally invasive technologies / X. Yu, S.P. Elliott, T.J.Wilt, A.M. McBean // Journal of Urology. – 2008. – Vol. 180, № 1. – P. 241–245.163. Pretreatment Features to Influence Effectiveness of Intravesical HyaluronicAcid Instillation in Refractory Interstitial Cystitis/Painful Bladder Syndrome / A.Kim, B. Lim, M.
Song, M.-S. Choo // International Neurourology Journal. – 2014.– Vol. 18. – P. 163-167.164. Prevention of recurrent bacterial cystitis by intravesical administration ofhyaluronic acid: a pilot study / C. Constantinides, T. Manousakas, P.Nikoiopoulos, A. Stanitsas // British Journal of Urology. – 2004. – Vol.
93. – № 9.– P. 1262–1266.165. Restoring the glycosaminoglycans layer in recurrent cystitis: experimentaland clinical foundations / A. Cicione [et al.] // International Journal of Urology. –2014. – Vol. 21, № 8. – P. 763-768.166. Riedl, C. Treatment costs of bladder pain syndrome/interstitial cystitis inAustria: a pharmacoeconomic approach following current guidelines / C. Riedl, P.Engelhardt, B. Schwarz // Clinical Drug Investigation. – 2013. – Vol. 33, № 10. –P. 737-742.167. Risk factors for lower urinary tract symptoms suggestive of benign prostatichyperplasia in a community based population of healthy aging men: the KrimpenStudy / E.T.
Kok [et al.] // Journal of Urology. – 2009. – Vol. 181, № 2. – P. 710716.168. Roehrborn,C.G.BenignPathophysiology,Epidemiology,ProstaticHyperplasia:Etiology,and Natural History / C.G. Roehrborn//Campbell-Walsh Urology. – 10-th ed. – 2012. – P. 2570- 2610.169. Roehrborn, C.G. BPH progression: concept and key learning from MTOPS,ALTESS, COMBAT, and ALF-ONE / C.G. Roehrborn // British Journal ofUrology. – 2008. – Vol. 101. – Suppl. 3. – P. 17–21.160170.
Role of inflammation in bladder function and interstitial cystitis / S. Grover[et al.] // Therapeutic Advances in Urology. – 2011. – Vol. 3, № 1. – Р. 19–33.171. Santos Dias, J. Benign prostatic hyperplasia: clinical manifestations andevaluation. / J. Santos Dias // Techniques in Vascular and InterventionalRadiology. – 2012. – Vol.
15, № 4. – P. 265-269.172. Schulz, A. Anti-inflammatory action of a hyaluronic acid-chondroitin sulfatepreparation in an in vitro bladder model / A. Schulz, A. Vestweber, D. Dressler //Aktuelle Urologie. – 2009. – Vol. 40, № 2. – P. 109-12.173. Solifenacin plus tamsulosin combination treatment in men with lowerurinary tract symptoms and bladder outlet obstruction: a randomized controlledtrial / W.D. Koltun [et al.] // European Urology. – 2013. – Vol. 63, № 1.
– P. 158–165.174. Sommariva, M. L. Efficacy of sodium hyaluronate in the management ofchemicalandradiationcystitis/M. L.Sommariva, S. D.Sandri, V.Ceriani // Minerva Urol Nefrol. – 2010. – Vol. 62, № 2. – P. 145-50.175. Stojadinovic, M.M. Predictors of surgical site infection in dirty urologicalsurgery / M.M. Stojadinovic, S.R.
Micґic, D.R. Milovanovic // InternationalJournal of Urology 2008. – № 15. – P. 699–7039.176. Teiichiro, A. Intravesical Non-Alkalinized Lidocaine Instillation forInterstitial Cystitis/Bladder Pain Syndrome Patients / A. Teiichiro, T. Masaaki //Journal of Urology. – 2012.
– № 2. – P. 223-226.177. The natural history of lower urinary tract dysfunction in men: minimum10-year urodynamic follow up of transurethral resection of prostate for bladderoutlet obstruction / A.W. Thomas [et al.] // Journal of Urology. – 2005. – Vol.174, № 5. – P. 1887–1891.178. The effects of combination therapy with dutasteride and tamsulosin onclinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-yearresults from the CombAT Study / C.G. Roehrborn [et al.] // European Urology.
–2010. – Vol. 57, № 1. – P. 123–131.179. The role of antimuscarinics in the management of men with symptoms of161overactive bladder associated with concomitant bladder outlet obstruction: anupdate / J.D. McConnell [et al.] // European Urology. – 2011. – Vol. 60, № 1. –P. 94-105.180. The role of pelvic floor excises on post-prostatectomy incontinence / A.Parekh [et al.] // Journal of Urology. – 2003.
– Vol. 170, № 1. – P. 130-133.181. Transurethral prostatectomy: immediate and postoperative complications.Cooperative study of 13 participating institutions evaluating 3,885 patients / W.Мebust, H. Holtgrewe, A. Cockett, P. Peters // Journal of Urology. – 2002. –Vol.167, № 1. – P. 5-9.182. Transurethral Resection of the Prostate / M.
Marszalek [et al.] // EuropeanUrology Supplements. – 2009, № 8. – Р. 504-512.183. Treatment of interstitial cystitis with Cystistat: a hyaluronic acid product /E.B. Kallestrup [et al.] // Scandinavian Journal of Urology and Nephrology.
–2005. – Vol. 39, № 2. – 143-147.184. Use of Hyaluronic Acid (Cystistat) for the Treatment of Late RadiationInduced Cystitis in Patients after Prostate Irrdiation / V. Kouloulias [et al.] //Journal Bioequiv Availab. – 2014. – № 6. – P. 18-22..
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
